Review
doi: 10.1038/nrc905.
Clinical translation of angiogenesis inhibitors
Affiliations
- PMID: 12360276
- DOI: 10.1038/nrc905
Item in Clipboard
Review
Clinical translation of angiogenesis inhibitors
Nat Rev Cancer.
2002 Oct.
Abstract
Angiogenesis inhibitors are a new class of drugs, for which the general rules involving conventional chemotherapy might not apply. The successful translation of angiogenesis inhibitors to clinical application depends partly on the transfer of expertise from scientists who are familiar with the biology of angiogenesis to clinicians. What are the most common questions that clinicians ask as they begin to test angiogenesis inhibitors in cancer clinical trials?
Similar articles
-
Angiogenesis inhibitors in cancer therapy.Curr Opin Investig Drugs. 2003 Jun;4(6):667-74. Curr Opin Investig Drugs. 2003. PMID: 12901224 Review.
-
Cancer research. Obstacle for promising cancer therapy.Science. 2002 Feb 22;295(5559):1444. doi: 10.1126/science.295.5559.1444a. Science. 2002. PMID: 11859164 No abstract available.
-
Clinical trials referral resource. Current clinical trials of thalidomide.Oncology (Williston Park). 2003 Mar;17(3):369-71, 374-5, 379-80. Oncology (Williston Park). 2003. PMID: 12661268 No abstract available.
-
[Bone marrow angiogenesis in multiple myeloma: new insights into the pathogenesis, and development of a new therapeutic approach].Rinsho Ketsueki. 2000 May;41(5):426-9. Rinsho Ketsueki. 2000. PMID: 10879105 Review. Japanese. No abstract available.
-
[The clinical perspective of angiogenesis inhibitors].Ned Tijdschr Geneeskd. 2003 Aug 30;147(35):1675-80. Ned Tijdschr Geneeskd. 2003. PMID: 14513538 Review. Dutch.
Cited by
-
Targeting the Renin-angiotensin-aldosterone System (RAAS) for Cardiovascular Protection and Enhanced Oncological Outcomes: Review.Curr Treat Options Oncol. 2024 Nov;25(11):1406-1427. doi: 10.1007/s11864-024-01270-9. Epub 2024 Oct 18. Curr Treat Options Oncol. 2024. PMID: 39422794 Review.
-
Targeting the tumour vasculature: from vessel destruction to promotion.Nat Rev Cancer. 2024 Oct;24(10):655-675. doi: 10.1038/s41568-024-00736-0. Epub 2024 Aug 29. Nat Rev Cancer. 2024. PMID: 39210063 Review.
-
Integrating Vascular Phenotypic and Proteomic Analysis in an Open Microfluidic Platform.ACS Nano. 2024 Sep 10;18(36):24909-24928. doi: 10.1021/acsnano.4c05537. Epub 2024 Aug 29. ACS Nano. 2024. PMID: 39208278 Free PMC article.
-
Tumor angiogenesis and anti-angiogenic therapy.Chin Med J (Engl). 2024 Sep 5;137(17):2043-2051. doi: 10.1097/CM9.0000000000003231. Epub 2024 Jul 25. Chin Med J (Engl). 2024. PMID: 39051171 Free PMC article. Review.
-
Tumor biomarkers for diagnosis, prognosis and targeted therapy.Signal Transduct Target Ther. 2024 May 20;9(1):132. doi: 10.1038/s41392-024-01823-2. Signal Transduct Target Ther. 2024. PMID: 38763973 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
